IRIS
VERDOIA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.032
NA - Nord America 2.879
AS - Asia 1.920
SA - Sud America 334
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.812
RU - Federazione Russa 810
IE - Irlanda 650
SG - Singapore 536
CN - Cina 509
DE - Germania 481
SE - Svezia 336
HK - Hong Kong 298
VN - Vietnam 281
UA - Ucraina 260
BR - Brasile 249
FR - Francia 147
IN - India 132
IT - Italia 93
FI - Finlandia 84
GB - Regno Unito 73
AR - Argentina 33
IR - Iran 33
MX - Messico 31
CA - Canada 30
ID - Indonesia 27
PL - Polonia 27
ZA - Sudafrica 18
BD - Bangladesh 17
NL - Olanda 16
ES - Italia 15
JP - Giappone 15
EC - Ecuador 14
IQ - Iraq 14
PY - Paraguay 11
CO - Colombia 9
CZ - Repubblica Ceca 9
KR - Corea 9
AT - Austria 8
LT - Lituania 7
TR - Turchia 7
UZ - Uzbekistan 7
VE - Venezuela 6
CL - Cile 5
MA - Marocco 5
PH - Filippine 5
UY - Uruguay 5
DZ - Algeria 4
EG - Egitto 4
PK - Pakistan 4
AU - Australia 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BJ - Benin 2
NG - Nigeria 2
OM - Oman 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.216
Salva come PNG Salva come JPEG
Città #
Dublin 650
Jacksonville 504
San Jose 324
Hong Kong 298
Dearborn 248
Singapore 203
Ashburn 191
Wilmington 168
Beijing 158
Moscow 120
Chandler 97
Lawrence 86
Princeton 86
Bremen 80
Los Angeles 80
Lauterbourg 78
Ho Chi Minh City 72
Hanoi 56
Düsseldorf 41
San Mateo 37
São Paulo 35
Buffalo 34
New York 32
Orem 30
Redondo Beach 28
Ann Arbor 23
Munich 23
Dong Ket 20
Frankfurt am Main 20
Santa Clara 19
Warsaw 19
Woodbridge 19
Haiphong 18
Leawood 18
Andover 17
Denver 17
Mexico City 17
Monmouth Junction 17
Houston 16
Chennai 15
Hefei 15
Nanjing 15
Johannesburg 14
Poplar 14
Tokyo 14
Ardabil 13
Bexley 13
Guangzhou 13
Helsinki 13
Kunming 13
Manchester 13
Norwalk 13
Piemonte 13
Torino 13
Brooklyn 11
Dallas 11
Seattle 11
Tianjin 11
Biên Hòa 10
Chicago 10
Montreal 10
Phoenix 10
Augusta 9
Brno 9
Council Bluffs 9
Fairfield 9
Seoul 9
Stockholm 9
Toronto 9
Zanjan 9
Amsterdam 8
Da Nang 8
Jakarta 8
Jinan 8
New Delhi 8
Nuremberg 8
Atlanta 7
Hangzhou 7
Novara 7
Shenyang 7
Tashkent 7
Belo Horizonte 6
Boston 6
London 6
Mumbai 6
San Francisco 6
Turku 6
Ankara 5
Baghdad 5
Guayaquil 5
Hải Dương 5
Montevideo 5
Sacramento 5
Shenzhen 5
Thái Bình 5
Wenzhou 5
Brasília 4
Buenos Aires 4
Bắc Giang 4
Cagliari 4
Totale 4.539
Salva come PNG Salva come JPEG
Nome #
Modulation of 1,25(OH)2D levels in cardiovascular system. Genetic regulation, impact on coronary artery disease, inflammation, platelet function and periprocedural myocardial injury after percutaneous coronary interventions 166
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 134
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 132
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 130
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 127
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 126
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 123
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 123
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 122
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 120
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 119
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 118
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 117
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 116
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 115
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 115
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 114
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 112
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 111
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 111
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 111
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 111
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 111
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 110
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 109
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 109
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 109
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 109
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 108
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 107
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 107
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 107
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 106
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 106
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 105
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 105
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 104
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 103
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 103
Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization. 101
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 100
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 100
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 98
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 96
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 96
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 96
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 96
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 95
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 93
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 93
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 92
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 92
Immature platelet fraction and the extent of coronary artery disease: A single centre study 91
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 91
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 91
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 90
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 90
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 88
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 86
Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study 85
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 84
Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy 83
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies. 81
Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease 81
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 81
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. 78
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 78
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy 77
Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study. 76
Two catheters for one perforation 76
Statins and elderly: From clinical trials to daily practice 76
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 75
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 73
Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment 73
Impact of aging on immature platelet count and its relationship with coronary artery disease 69
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis 68
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study. 65
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 64
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve 64
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy 64
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents 63
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention 63
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease 61
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention 61
Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation 60
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI 59
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort study 57
Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials 51
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management 12
Totale 8.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 0 0 0 0 20 87 20
2021/2022502 23 40 38 34 47 7 15 13 32 29 105 119
2022/20231.278 92 52 85 6 108 107 25 85 645 3 45 25
2023/2024448 30 40 35 6 69 0 48 7 1 4 142 66
2024/2025739 23 15 23 2 41 5 81 128 189 73 10 149
2025/20263.324 168 120 273 603 302 258 629 612 188 171 0 0
Totale 8.424